Institutional investors hold a majority ownership of ABT through the 71.22% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended March 2016, these large investors purchased a net $1.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 7.1 Million shares of Abbott Laboratories
MONDRIAN INVESTMENT PARTNERS LTD... Bought 6.4 Million shares of Abbott Laboratories
FLOSSBACH VON STORCH AG Bought 5.3 Million shares of Abbott Laboratories